tradingkey.logo
tradingkey.logo
Search

Accuray Inc

ARAY
Add to Watchlist
0.268USD
-0.017-5.93%
Close 07-31 16:00ETQuotes delayed by 15 min
32.02MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-5.93%

5 Days

+12.46%

1 Month

+4.00%

6 Months

-66.79%

Year to Date

-67.49%

1 Year

-79.53%

Key Figures
0.266Open
0.288High
1.90MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.60%Turnover Ratio
0.285Prev. Close
0.258Low
337.95KTurnover
LossP/E Static
0.76P/B
0.00%Div Yield TTM
-9.90%ROA
2.10052wk High
0.64Volume Ratio
-1.59MNet Profit
118.93MShares
-0.3780EPS TTM
1.34Beta
-101.06%ROE
0.33052wk Low
10.63%Amplitude
23.76%Gross Margin
32.02MMarket Cap
2.03Reward/Risk
5.81%Risk Rate

TradingKey Stock Score of Accuray Inc

Currency: USD Updated: 2026-07-31

Key Insights

Accuray Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 82 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 0.35.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Accuray Inc's Score

Industry at a Glance

Industry Ranking
82 / 199
Overall Ranking
168 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Accuray Inc Highlights

StrengthsRisks
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Overvalued
The company’s latest PE is -0.71, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 85.92M shares, decreasing 3.71% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 2.71K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.04.

Analyst Rating

Based on 1 analysts
Hold
Current Rating
0.350
Target Price
+51.58%
Upside Space

Accuray Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 1 analysts
Hold
Current Rating
0.350
Target Price
+51.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Accuray Inc
ARAY
1
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
29
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18

Indicators

Indicators
Sell(1)
Neutral(4)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.011
Neutral
RSI(14)
50.001
Neutral
STOCH(KDJ)(9,3,3)
56.098
Buy
ATR(14)
0.025
Low Volatility
CCI(14)
82.867
Neutral
Williams %R
39.875
Buy
TRIX(12,20)
-0.855
Sell
StochRSI(14)
78.306
Neutral
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
0.250
Buy
MA10
0.247
Buy
MA20
0.254
Buy
MA50
0.302
Sell
MA100
0.351
Sell
MA200
0.655
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Accuray Inc Info

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Ticker SymbolARAY
CompanyAccuray Inc
CEOLa Neve (Stephen R)
Websitehttps://www.accuray.com/

Shareholders

Shareholders
Shareholders
Proportion
TCW Asset Management Company LLC
13.00%
BlackRock Institutional Trust Company, N.A.
6.02%
Aevum Fondation de Prévoyance
4.60%
Weber Capital Management, LLC
4.25%
Neuberger Berman, LLC
4.18%
Other
67.95%

FAQs

What is the current price of Accuray Inc (ARAY)?

The current price of Accuray Inc (ARAY) is 0.27.

What is the symbol of Accuray Inc?

The ticker symbol of Accuray Inc is ARAY.

What is the 52-week high of Accuray Inc?

The 52-week high of Accuray Inc is 2.10.

What is the 52-week low of Accuray Inc?

The 52-week low of Accuray Inc is 0.33.

What is the market capitalization of Accuray Inc?

The market capitalization of Accuray Inc is 31.93M.

Is Accuray Inc (ARAY) currently rated as Buy, Hold, or Sell?

According to analysts, Accuray Inc (ARAY) has an overall rating of signal_hold, with a price target of 0.35.

What is the Earnings Per Share (EPS TTM) of Accuray Inc (ARAY)?

The Earnings Per Share (EPS TTM) of Accuray Inc (ARAY) is -0.02.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.